Sublingual immunotherapy in the treatment of children

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 61, Issue 81, 2006, Pages 7-10

  Pham Thi, N ^a   De Blic, J ^a   Scheinmann, P ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b Descartes PARIS 5 Site Necker Enfants Malades   (France)

Author keywords

Allergic rhinitis immune modulation; Asthma; Children; Compliance; Sublingual immunotherapy

Indexed keywords

ALLERGEN; ANTIASTHMATIC AGENT; FLUTICASONE PROPIONATE; GRASS POLLEN EXTRACT; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; POLLEN ANTIGEN;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ANAPHYLAXIS; CHILDHOOD; CLINICAL TRIAL; DERMATOPHAGOIDES; DESENSITIZATION; DIARRHEA; DRUG DOSE REDUCTION; DRUG FORMULATION; DRUG POTENTIATION; DRUG SAFETY; ECONOMIC ASPECT; FOOD ALLERGY; GASTROINTESTINAL SYMPTOM; HAY FEVER; HOUSE DUST ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; MOUTH DISCOMFORT; PATIENT COMPLIANCE; POLLEN ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; REVIEW; RISK REDUCTION; SYMPTOM; T LYMPHOCYTE; TREATMENT DURATION; URTICARIA; WHEEZING; AGE DISTRIBUTION; ALLERGY; ASTHMA; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG ADMINISTRATION ROUTE; GRASS POLLEN; META ANALYSIS; PERENNIAL RHINITIS; REGULATORY T LYMPHOCYTE; RHINITIS; RHINOCONJUNCTIVITIS; RISK ASSESSMENT; SKIN ALLERGY; SKIN TEST; SUBLINGUAL IMMUNOTHERAPY; SYSTEMATIC REVIEW; TREATMENT WITHDRAWAL; CHILD; DRUG ADMINISTRATION; IMMUNOLOGY; PEDIATRICS; PRESCHOOL CHILD; SUBLINGUAL DRUG ADMINISTRATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ASTHMA; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; DESENSITIZATION, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; HUMANS; PATIENT COMPLIANCE; PEDIATRICS; RHINITIS;

EID: 33744775696     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2006.01162.x     Document Type: Review

References (36)

1. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 108: S147 S334.
2. Bousquet J, Lockey R, Malling HJ. WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic disease. Allergy (Suppl) 1998 53: 1 42.
3. Andre C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000 121: 229 234.
4. Di Rienzo V, Minelli M, Musarra A, Sambugaro R, Pecora S, Canonica GW et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Clin Exp Allergy 2005 35: 560 564.
5. Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003 33: 206 210.
6. Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more. Allergy 2004 59: 1205 1210.
7. Baena-Cagnani CE, Passalacqua G, Baena-Cagnani RC, Croce VH, Canonica WG. Sublingual immunotherapy in pediatric patients: beyond clinical efficacy. Curr Opin Allergy Clin Immunol 2005 5: 173 177.
8. Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study. Allergol Immunopathol (Madr) 1990 18: 277 284.
9. Vourdas D, Syrigou E, Potamianou P, Carat F, Batard T, Andre C et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998 53: 662 672.
10. Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000 55: 842 849.
11. Caffarelli C, Sensi LG, Marcucci F, Cavagni G. Preseasonal local allergoid immunotherapy to grass pollen in children: a double-blind, placebo-controlled, randomized trial. Allergy 2000 55: 1142 1147.
12. Bahceciler NN, Isik U, Barlan IB, Basaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol 2001 32: 49 55.
13. Ippoliti F, De Santis W, Volterrani A, Lenti L, Canitano N, Lucarelli S et al. Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 2003 14: 216 221.
14. Wuthrich B, Bucher C, Jorg W, Bircher A, Eng P, Schneider Y et al. Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen. J Investig Allergol Clin Immunol 2003 13: 145 148.
15. Rolinck-Werninghaus C, Wolf H, Liebke C, Baars JC, Lange J, Kopp MV et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy 2004 59: 1285 1293.
16. Malling HJ. Sublingual immunotherapy: efficacy - methodology and outcome of clinical trials. Allergy 2006 61 Suppl. 81 24 28.
17. Pajno GB, Barberio G, De LF, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy 2001 31: 1392 1397.
18. La Rosa M, Ranno C, Andre C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999 104: 425 432.
19. Tonnel AB, Scherpereel A, Douay B, Mellin B, Leprince D, Goldstein N et al. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Allergy 2004 59: 491 497.
20. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005 60: 4 12.
21. Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De ME et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004 114: 851 857.
22. Bufe A, Ziegler-Kirbach E, Stoeckmann E, Heidemann P, Gehlhar K, Holland-Letz T et al. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Allergy 2004 59: 498 504.
23. Marcucci F, Sensi L, Di CG, Salvatori S, Bernini M, Pecora S et al. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy. Pediatr Allergy Immunol 2005 16: 519 526.
24. Pajno GB, Vita D, Parmiani S, Caminiti L, La Grutta S, Barberio G. Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate. Clin Exp Allergy 2003 33: 1641 1647.
25. Pajno GB. Allergen immunotherapy in early childhood: between Scylla and Charybdis! Clin Exp Allergy 2005 35: 551 553.
26. Moingeon P, Batard T, Fadel R, Frati F, Sieber J, Overtvelt L. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 2006 61: 151 165.
27. Roberts G, Hurley C, Turcanu V, Lack G. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 2006 117: 263 268.
28. Ciprandi G, Fenoglio D, Cirillo I, Milanese M, Minuti P. Sublingual immunotherapy and regulatory T cells. Allergy 2006 61: 511 513.
29. Smith H, White P, Annila I, Poole J, Andre C, Frew A. Randomized controlled trial of high-dose sublingual immunotherapy to treat seasonal allergic rhinitis. J Allergy Clin Immunol 2004 114: 831 837.
30. Enrique E, Pineda F, Malek T, Bartra J, Basagana M, Tella R et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005 116: 1073 1079.
31. Pajno GB, Peroni DG, Vita D, Pietrobelli A, Parmiani S, Boner AL. Safety of sublingual immunotherapy in children with asthma. Paediatr Drugs 2003 5: 777 781.
32. Gidaro GB, Marcucci F, Sensi L, Incorvaia C, Frati F, Ciprandi G. The safety of sublingual-swallow immunotherapy: an analysis of published studies. Clin Exp Allergy 2005 35: 565 571.
33. Bousquet J, Scheinmann P, Guinnepain MT, Perrin-Fayolle M, Sauvaget J, Tonnel AB et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999 54: 249 260.
34. Fiocchi A, Pajno G, La Grutta S, Pezzuto F, Incorvaia C, Sensi L et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol 2005 95: 254 258.
35. Pajno GB, Vita D, Caminiti L, Arrigo T, Lombardo F, Incorvaia C et al. Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol 2005 116: 1380 1381.
36. Lombardi C, Gani F, Landi M, Falagiani P, Bruno M, Canonica GW et al. Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol 2004 113: 1219 1220.